The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients

被引：0
|
作者：
Mary Jo Fidler
Cristina L. Fhied
Joanna Roder
Sanjib Basu
Selina Sayidine
Ibtihaj Fughhi
Mark Pool
Marta Batus
Philip Bonomi
Jeffrey A. Borgia
机构：
[1] Sections of Medical Oncology at Rush University Medical Center,Departments of Pathology and Cell & Molecular Medicine
[2] Pathology,undefined
[3] Rush University Medical Center,undefined
[4] Biodesix,undefined
[5] Inc,undefined
[6] Preventative Medicine,undefined
[7] Rush University Medical Center,undefined
[8] Cell and Molecular Medicine at Rush University Medical Center,undefined
[9] Rush University Medical Center,undefined
来源：
BMC Cancer | / 18卷
关键词：
Biomarker; Serum; Non-small cell lung cancer (NSCLC); Erlotinib; Luminex; VeriStrat;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Circulating endothelial cells as a biomarker in non-small cell lung cancer patients: correlation with clinical outcome
    Najjar, Fadi
    Alammar, Moosheer
    Bachour, Marroan
    Al-Massarani, Ghassan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2014, 29 (04): : E337 - E344
  • [42] A multi-analyte serum test for the detection of non-small cell lung cancer
    E C Farlow
    M S Vercillo
    J S Coon
    S Basu
    A W Kim
    L P Faber
    W H Warren
    P Bonomi
    M J Liptay
    J A Borgia
    British Journal of Cancer, 2010, 103 : 1221 - 1228
  • [43] A multi-analyte serum test for the detection of non-small cell lung cancer
    Farlow, E. C.
    Vercillo, M. S.
    Coon, J. S.
    Basu, S.
    Kim, A. W.
    Faber, L. P.
    Warren, W. H.
    Bonomi, P.
    Liptay, M. J.
    Borgia, J. A.
    BRITISH JOURNAL OF CANCER, 2010, 103 (08) : 1221 - 1228
  • [44] Outcome of elderly patients with advanced non-small cell lung cancer.
    Gumus, M
    Palak, B
    Iyikesici, S
    Yumuk, PF
    Seker, M
    Topal, A
    Dane, F
    Salepci, T
    Yayla, A
    Turhal, NS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 706S - 706S
  • [45] Time Trends of Surgical Outcome in Patients with Non-small Cell Lung Cancer
    Hanagiri, Takeshi
    Baba, Tetsuro
    So, Tetsuya
    Yasuda, Manabu
    Sugaya, Masakazu
    Ono, Kenji
    So, Tomoko
    Uramoto, Hidetaka
    Takenoyama, Mitsuhiro
    Yasumoto, Kosei
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : 825 - 829
  • [46] Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group
    Umemura, Shigeki
    Tsubouchi, Kazuya
    Yoshioka, Hiroshige
    Hotta, Katsuyuki
    Takigawa, Nagio
    Fujiwara, Keiichi
    Horita, Naokatsu
    Segawa, Yoshihiko
    Hamada, Noboru
    Takata, Ichiro
    Yamane, Hiromichi
    Kamei, Haruhito
    Kiura, Katsuyuki
    Tanimoto, Mitsune
    LUNG CANCER, 2012, 77 (01) : 134 - 139
  • [47] ASSESSING THE UTILIZATION OF DIABETIC NON-SMALL CELL LUNG CANCER PATIENTS COMPARED TO NON-SMALL CELL LUNG CANCER PATIENTS
    Ruban, C.
    Blanchette, C. M.
    Howden, R.
    Kowalkowski, M.
    Marino, J.
    Saunders, W.
    VALUE IN HEALTH, 2017, 20 (09) : A511 - A511
  • [48] Clinical relevance of serum miR-9 in resected non-small cell lung cancer patients
    Zhao, Lin
    Liang, Yihong
    Zhuang, Wei
    Liang, Xueyang
    Xu, Ailing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (10): : 19764 - 19770
  • [49] Prognostic impact of serum transthyretin in patients with non-small cell lung cancer
    Shimura, Tatsuo
    Shibata, Masahiko
    Inoue, Takuya
    Owada-Ozaki, Yuki
    Yamaura, Takumi
    Muto, Satoshi
    Hasegawa, Takeo
    Shio, Yutaka
    Suzuki, Hiroyuki
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (06) : 597 - 604
  • [50] TRYPTOPHAN METABOLITES IN SERUM AND FECES OF PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Zlatnik, E. Yu
    Sagakyants, A. B.
    Shatova, O. P.
    Zabolotneva, A. A.
    Appolonova, S. A.
    Moskaleva, N. E.
    Meshkov, I. O.
    Rumyantsev, S. A.
    Shestopalov, A., V
    YAKUT MEDICAL JOURNAL, 2021, (04): : 89 - 92
12345